Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Si-Bone (SIBN) Research & Development (2017 - 2025)

Historic Research & Development for Si-Bone (SIBN) over the last 9 years, with Q3 2025 value amounting to $4.2 million.

  • Si-Bone's Research & Development rose 623.59% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year increase of 61.12%. This contributed to the annual value of $16.6 million for FY2024, which is 1019.43% up from last year.
  • Latest data reveals that Si-Bone reported Research & Development of $4.2 million as of Q3 2025, which was up 623.59% from $4.3 million recorded in Q2 2025.
  • Si-Bone's 5-year Research & Development high stood at $4.5 million for Q1 2025, and its period low was $3.0 million during Q1 2021.
  • Moreover, its 5-year median value for Research & Development was $3.7 million (2023), whereas its average is $3.7 million.
  • In the last 5 years, Si-Bone's Research & Development skyrocketed by 4545.03% in 2021 and then plummeted by 807.26% in 2023.
  • Quarter analysis of 5 years shows Si-Bone's Research & Development stood at $3.0 million in 2021, then increased by 14.14% to $3.5 million in 2022, then increased by 19.6% to $4.2 million in 2023, then decreased by 7.02% to $3.9 million in 2024, then increased by 9.61% to $4.2 million in 2025.
  • Its Research & Development was $4.2 million in Q3 2025, compared to $4.3 million in Q2 2025 and $4.5 million in Q1 2025.